Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology
- PMID: 21509508
- DOI: 10.1007/s11064-011-0475-5
Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology
Abstract
Extracellular accumulations of Aβ, hyperphosphorylation of tau and intracellular neurofibrillary tangle formation have been the hallmarks of Alzheimer's Disease (AD). Although tau and its phosphorylation play a pivotal role in the normal physiology yet its hyperphosphorylation has been a pathological manifestation in neurodegenerative disorders like AD. In this review physiology of tau, its phosphorylation, hyperphosphorylation with the intervention of various kinases, aggregation and formation of paired helical filaments has been discussed. A brief account of various animal models employed to study the pathological manifestation of tau in AD and therapeutic strategies streamlined to counter the tau induced pathology has been given. The reasons for the failure to have suitable animal model to study AD pathology and recent success in achieving this has been included. The role of caspase cascade in tau cleavage has been emphasized. The summary of current studies on tau and the need for future studies has been accentuated.
Similar articles
-
Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease.Curr Alzheimer Res. 2010 Dec;7(8):708-16. doi: 10.2174/156720510793611556. Curr Alzheimer Res. 2010. PMID: 20678071 Review.
-
Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.J Alzheimers Dis. 2013;33 Suppl 1:S123-39. doi: 10.3233/JAD-2012-129031. J Alzheimers Dis. 2013. PMID: 22710920 Review.
-
Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.J Neural Transm Suppl. 1998;53:169-80. doi: 10.1007/978-3-7091-6467-9_15. J Neural Transm Suppl. 1998. PMID: 9700655 Review.
-
AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.Acta Neuropathol. 2011 Mar;121(3):337-49. doi: 10.1007/s00401-010-0759-x. Epub 2010 Oct 19. Acta Neuropathol. 2011. PMID: 20957377 Free PMC article.
-
A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.J Alzheimers Dis. 2010;21(2):445-70. doi: 10.3233/JAD-2010-100120. J Alzheimers Dis. 2010. PMID: 20571215
Cited by
-
Extrasynaptic NMDA receptor-induced tau overexpression mediates neuronal death through suppressing survival signaling ERK phosphorylation.Cell Death Dis. 2016 Nov 3;7(11):e2449. doi: 10.1038/cddis.2016.329. Cell Death Dis. 2016. PMID: 27809304 Free PMC article.
-
Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.Curr Neuropharmacol. 2013 Jul;11(4):414-29. doi: 10.2174/1570159X11311040005. Curr Neuropharmacol. 2013. PMID: 24381531 Free PMC article.
-
Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model.Brain Pathol. 2014 Apr;24(3):261-9. doi: 10.1111/bpa.12116. Epub 2014 Feb 12. Brain Pathol. 2014. PMID: 24329968 Free PMC article.
-
Establishment of a Drosophila AD model.J Biol Methods. 2016 Jun 7;3(2):e43. doi: 10.14440/jbm.2016.61. eCollection 2016. J Biol Methods. 2016. PMID: 31453210 Free PMC article.
-
P2Y receptors in Alzheimer's disease.Biol Cell. 2015 Jan;107(1):1-21. doi: 10.1111/boc.201400043. Epub 2014 Oct 13. Biol Cell. 2015. PMID: 25179475 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical